Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
145,8 SAR | +0,14% |
|
0,00% | +26,78% |
Attività
Vendite per attività
SAR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
86,9
%
| 797 | 87,0 % | 957 | 86,9 % | +19,98% |
Consumer Health Products
13,1
%
| 119 | 13,0 % | 144 | 13,1 % | +20,78% |
Vendite per regione
SAR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Saudi Arabia
65,5
%
| 587 | 64,1 % | 721 | 65,5 % | +22,73% |
Gulf Cooperation Council
12,7
%
| 109 | 11,9 % | 140 | 12,7 % | +28,73% |
Iraq
9,6
%
| 91 | 9,9 % | 105 | 9,6 % | +15,34% |
North Africa and Other Export Markets
6,9
%
| 66 | 7,1 % | 76 | 6,9 % | +15,89% |
Egypt
5,4
%
| 64 | 7,0 % | 59 | 5,4 % | -7,69% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Tarek Hosni
CEO | Chief Executive Officer | 60 | 15/05/21 |
Anwer Muhiddein
DFI | Director of Finance/CFO | 60 | 13/01/13 |
Mohammed Jamjoom
COO | Chief Operating Officer | 29 | 01/09/21 |
Hussam Salousa
PRN | Corporate Officer/Principal | 48 | 04/09/22 |
Mohammed Batarfi
HRO | Human Resources Officer | 40 | 01/02/22 |
Essam Al Sayed
SAM | Sales & Marketing | 57 | 14/10/21 |
Hisham Ahmed
SAM | Sales & Marketing | 57 | 01/07/21 |
Alaa Gamaleldin
PRN | Corporate Officer/Principal | 55 | 25/07/21 |
Wagih El Bokl
PRN | Corporate Officer/Principal | 56 | 10/07/21 |
Idrees Siddiqu
PRN | Corporate Officer/Principal | 57 | 01/03/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Faris AlGhannam
BRD | Director/Board Member | - | 19/06/22 |
Chairman | 64 | 19/06/22 | |
Founder | 39 | 19/06/22 | |
Director/Board Member | 96 | 19/06/22 | |
Director/Board Member | 63 | 19/06/22 | |
Director/Board Member | 41 | 19/06/22 | |
Director/Board Member | 79 | 19/06/22 | |
Director/Board Member | 44 | 19/06/22 | |
Director/Board Member | - | 19/06/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 70 000 000 | 21 000 000 ( 30,00 %) | 0 | 30,00 % |
Coordinate società
Jamjoom Pharmaceuticals Factory Co.
Jeddah Industrial City Phase Five
21442, Jeddah
+
http://www.jamjoompharma.com![Indirizzo Jamjoom Pharmaceuticals Factory Company(4015)](https://cdn.zonebourse.com/static/address/155977412.png)
Settore
Vendite per attività
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Fatturato trimestrale - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
+26,78% | 2,72 Mrd | |
+25,24% | 45,32 Mrd | |
+34,85% | 24,51 Mrd | |
+29,56% | 16,85 Mrd | |
+21,32% | 14,62 Mrd | |
+70,51% | 14,16 Mrd | |
-0,05% | 6,79 Mrd | |
+15,74% | 5,82 Mrd | |
-8,87% | 5,73 Mrd | |
+10,29% | 4,93 Mrd |
- Borsa valori
- Azioni
- Azione 4015
- Società Jamjoom Pharmaceuticals Factory Company